非小细胞肺癌术后自身抗体水平及临床意义OA
Postoperative autoantibody levels and clinical significance in non-small cell lung cancer
目的 探讨非小细胞肺癌(non-small cell lung cancer,NSCLC)患者手术前后肿瘤相关 7 项自身抗体(tumor-associated autoantibody,TAAB),包括肿瘤蛋白 53(tumor protein 53,p53)、蛋白基因产物 9.5(protein gene product 9.5,PGP9.5)、性别决定基因家族 2(SRY-box containing gene 2,SOX2)、G抗原7(G antigen 7 ATP-dependent RNA helicase,GAGE7)、ATP结合RNA 解螺旋酶(ATP-dependent RNA helicase,GBU4-5)、人黑色素瘤抗原 A1(melanoma antigen A1,MAGE A1)、肿瘤/睾丸抗原(cancer/testis antigen,CAGE)表达水平动态变化的临床意义.方法 选取 2019 年 1 月至2022 年 8 月在宁波市医疗中心李惠利医院胸外科接受手术治疗的 NSCLC 患者 41 例,采用酶联免疫吸附法(enzyme linked immunosorbent assay,ELISA)检测患者血清 7 项TAAB表达水平.结果 鳞癌组PGP9.5 手术前后表达水平均明显高于腺癌组(P<0.05),腺癌组GAGE7 手术前后表达水平均明显高于鳞癌组(P<0.05).鳞癌组术后 1 周GBU4-5 表达水平明显高于腺癌组(Z=-2.095,P=0.036).腺癌组内,术后 1 周GBU4-5(P=0.027)、CAGE(P=0.042)表达水平较术前明显下降.术后 6 个月PGP9.5(P=0.004)、GAGE7(P<0.001)、GBU4-5(P=0.014)表达水平较术前明显下降.鳞癌组中,术后 1 周表达水平差异均无统计学意义(P>0.05).术后 6 个月SOX2(P=0.011)表达水平较术前明显下降.与术前比较,术后 1 周GBU4-5 表达水平明显下降(P=0.009).术后 6 个月PGP9.5(P=0.003)、GAGE7(P=0.001)、GBU4-5(P=0.013)表达水平明显下降.结论 手术干预可降低NSCLC患者 7 项TAAB表达水平,手术治疗前后监测 7项TAAB有助于NSCLC患者手术疗效的评估和术后病情进展的预测.
Objective To investigate the clinical significance of dynamic changes in the expression levels of tumor associated autoantibody(TAAB),including tumor protein 53(p53),protein gene product 9.5(PGP9.5),SRY-box containing gene 2(SOX2),G antigen 7 ATP-dependent RNA helicase(GAGE7),ATP-dependent RNA helicase(GBU4-5),melanoma antigen A1(MAGE A1),cancer/testis antigen(CAGE)in non-small cell lung cancer(NSCLC)patients before and after surgery.Methods Forty-one patients with NSCLC who underwent surgical treatment at the Department of Thoracic Surgery of Li Huili Hospital,Ningbo Medical Center,were selected from January 2019 to August 2022.Enzyme linked immunosorbent assay(ELISA)was used to detect the expression levels of seven TAAB markers in the serum of 41 NSCLC patients undergoing surgical treatment.Results The expression levels of PGP9.5 were found to be significantly higher in the squamous cancer group than in the adenocarcinoma group(P<0.05),while the expression levels of GAGE7 were found to be significantly higher in the adenocarcinoma group than in the squamous cancer group(P<0.05).The expression level of GBU4-5 was found to be significantly higher in the squamous carcinoma group than in the adenocarcinoma group at one week after surgery(Z=-2.095,P=0.036).Within the adenocarcinoma group,the expression levels of GBU4-5(P=0.027)and CAGE(P=0.042)were found to be significantly lower at one week after surgery compared with those before surgery.The expression levels of PGP9.5(P=0.004),GAGE7(P<0.001),and GBU4-5(P=0.014)were found to have decreased significantly at six months postoperatively in comparison to their preoperative levels.In the squamous cancer group,no statistically significant differences were observed in the expression levels at one week after surgery.The expression level of SOX2(P=0.011)exhibited a statistically significant decrease at six months postoperatively in comparison to the preoperative levels.Similarly,the expression level of GBU4-5 was found to be significantly decreased at one week postoperatively in comparison to the preoperative levels(P=0.009).The expression levels of PGP9.5(P=0.003),GAGE7(P=0.001),and GBU4-5(P=0.013)were found to have decreased significantly at six months postoperatively.Conclusion Surgical intervention can reduce the expression level of 7 TAABs in NSCLC patients.Monitoring 7 TAABs before and after surgical treatment is helpful to predict the surgical efficacy and postoperative disease progression of NSCLC patients.
王泽仪;穆银玉;谢服役
宁波市医疗中心李惠利医院检验科,浙江宁波 3150401
临床医学
非小细胞肺癌肿瘤相关自身抗体肺切除术预测
Non-small cell lung cancerTumor-associated autoantibodiesPneumonectomyForecasting
《中国现代医生》 2024 (023)
16-20 / 5
浙江省医药卫生科技计划项目(2023KY246,2019KY606)
评论